Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4h-pyran-4-one, 3-hydroxy-2-methyl-, Gallium Salt (3:1)
2. Tris(3-hydroxy-2-methyl-4h-pyran-4-onato)gallium(iii)
3. Tris(maltolato)gallium(iii)
1. 108560-70-9
2. Gallium Tris(2-methyl-4-oxo-4h-pyran-3-olate)
3. 17lei49c2g
4. Gallium Maltolate [inci]
5. Gallium;2-methyl-4-oxopyran-3-olate
6. Db05420
7. B2699-054157
8. 3-bis[(2-methyl-4-oxopyran-3-yl)oxy]gallanyloxy-2-methylpyran-4-one
9. Gallium, Tris(3-(hydroxy-.kappa.o)-2-methyl-4h-pyran-4-onato-.kappa.o4)-, (oc-6-21)-
Molecular Weight | 445.0 g/mol |
---|---|
Molecular Formula | C18H15GaO9 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 0 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 148 |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 200 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Investigated for use/treatment in bladder cancer, lymphoma (unspecified), multiple myeloma, paget's disease, and prostate cancer.
Gallium maltolate is a novel orally active formulation of gallium, a semi-metallic element that is a potent inhibitor of ribonucleotide reductase, an enzyme that promotes tumor growth.Gallium is also known to concentrate in malignant tumors and sites of infection, and appears to favorably impact calcium deposition, making bones more resistant to degradation caused by cancer metastasis. Titan's novel product, gallium maltolate, may significantly expand the therapeutic potential of gallium by providing the advantages of enhanced bioavailablity, a potentially improved therapeutic profile and ease of administration.
ABOUT THIS PAGE
A Gallium Maltolate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gallium Maltolate, including repackagers and relabelers. The FDA regulates Gallium Maltolate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gallium Maltolate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gallium Maltolate supplier is an individual or a company that provides Gallium Maltolate active pharmaceutical ingredient (API) or Gallium Maltolate finished formulations upon request. The Gallium Maltolate suppliers may include Gallium Maltolate API manufacturers, exporters, distributors and traders.
Gallium Maltolate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gallium Maltolate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gallium Maltolate GMP manufacturer or Gallium Maltolate GMP API supplier for your needs.
A Gallium Maltolate CoA (Certificate of Analysis) is a formal document that attests to Gallium Maltolate's compliance with Gallium Maltolate specifications and serves as a tool for batch-level quality control.
Gallium Maltolate CoA mostly includes findings from lab analyses of a specific batch. For each Gallium Maltolate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gallium Maltolate may be tested according to a variety of international standards, such as European Pharmacopoeia (Gallium Maltolate EP), Gallium Maltolate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gallium Maltolate USP).
LOOKING FOR A SUPPLIER?